What is O2M Technologies?
O2M Technologies is at the forefront of oxygen imaging technology, leveraging patented pulse electron paramagnetic resonance to generate rapid, three-dimensional partial oxygen pressure (pO₂) maps within tissues. Their flagship JIVA-25 preclinical oxygen imager and associated contract research services are pivotal for advancing cancer research, diagnostics, and drug development. By providing precise oxygen distribution data, O2M Technologies aims to significantly enhance clinical diagnostics and therapeutic efficacy.
How much funding has O2M Technologies raised?
O2M Technologies has raised a total of $81K across 1 funding round:
Debt
$81K
Debt (2021): $81K with participation from PPP
What's next for O2M Technologies?
With significant Series B/C stage backing, O2M Technologies is poised for accelerated growth and market penetration. The substantial expansion capital will likely fuel further research and development of their oxygen imaging solutions, potentially leading to new product iterations and expanded applications in both research and clinical settings. Strategic partnerships and broader adoption of their technology are anticipated as the company solidifies its position as a leader in advanced diagnostic imaging.
See full O2M Technologies company page
